fluorodeoxyglucose f18 has been researched along with Hypopharyngeal Neoplasms in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (7.14) | 18.2507 |
2000's | 16 (28.57) | 29.6817 |
2010's | 33 (58.93) | 24.3611 |
2020's | 3 (5.36) | 2.80 |
Authors | Studies |
---|---|
Fukugawa, Y; Hirai, T; Matsuyama, T; Murakami, D; Orita, Y; Oya, N; Saito, T; Shiraishi, S; Toya, R; Watakabe, T | 1 |
Chan, SC; Cheng, NM; Hsieh, CH; Liao, CT; Ng, SH; Wong, CK; Yen, TC | 1 |
Al-Mamgani, A; Gouw, ZAR; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; Vogel, WV | 1 |
Birchall, J; Breik, O; Jones, K; Kumar, A; Laugharne, D; Mortimore, S | 1 |
Fujimoto, Y; Hanai, N; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Kodaira, T; Naganawa, S; Nishio, M; Sone, M; Suzuki, H; Tamaki, T | 1 |
Hamasaki, T; Hanamoto, A; Hatazawa, J; Inohara, H; Isohashi, F; Kishikawa, T; Konishi, K; Michiba, T; Miyabe, J; Nakahara, S; Ogawa, K; Suzuki, M; Takemoto, N; Takenaka, Y; Tatsumi, M; Yoshioka, Y | 1 |
Higashiyama, S; Hosono, M; Iguchi, H; Kawabe, J; Miki, Y; Oishi, M; Okazaki, E; Shiomi, S; Teranishi, Y | 1 |
Kuwabara, H; Tateishi, U; Toda, K; Toriihara, A; Yoshimura, R; Yuasa-Nakagawa, K | 1 |
Huber, GF; Huellner, MW; Meerwein, CM; Morand, GB; Pizzuto, DA; Stolzmann, P; Vital, D | 1 |
Broglie, MA; Huber, AM; Huber, GF; Hüllner, MW; Morand, GB; Rupp, NJ; Werner, J | 1 |
Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
Hanai, N; Hasegawa, Y; Hirakawa, H; Hosoi, H; Kawakita, D; Masui, T; Nishio, M; Ozawa, T; Terada, A | 1 |
Chan, SC; Chang, JT; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
Cho, KJ; Choi, SH; Kang, BC; Kim, JS; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Roh, JL | 1 |
Kang, WJ; Kim, J; Koh, YW; Lee, JH; Shin, NY; Sohn, B | 1 |
Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Lee, YS; Nam, IC; Park, JO; Yoo, IeR | 1 |
Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Lee, DS; Pak, K | 1 |
Aleknavičius, E; Burneckis, A; Daisne, JF; Grybauskas, M | 1 |
Cho, KJ; Choi, SH; Kang, BC; Kim, JS; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Oh, JS; Roh, JL | 1 |
Chan, SC; Chang, CJ; Chang, JT; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
Kang, WJ; Kim, J; Koh, YW; Lee, HJ; Lee, JH; Woo, HY | 1 |
Ang, KK; Foote, R; Garden, AS; Harari, P; Harris, J; Holland, J; Jones, CU; Le, QT; Levering, A; Opanowski, A; Rosenthal, DI; Schwartz, DL; Trotti, AM; Yao, M; Zhang, Q | 1 |
Chan, SC; Chang, JT; Fan, KH; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yang, LY; Yen, TC | 1 |
Baumann, M; Bergmann, R; Beuthien-Baumann, B; Brüchner, K; Jentsch, C; Kotzerke, J; Krause, M; Löck, S; Mosch, B; Steinbach, J; Thames, H; Troost, EGC; Yaromina, A; Zips, D | 1 |
Caldas-Magalhaes, J; Jager, EA; Kasperts, N; Ligtenberg, H; Pameijer, FA; Philippens, ME; Raaijmakers, CP; Schakel, T; Terhaard, CH; Willems, SM | 1 |
Ejima, Y; Ishihara, T; Kitajima, K; Kiyota, N; Komatsu, H; Nibu, KI; Otsuki, N; Sasaki, R; Suenaga, Y; Takahashi, S | 1 |
Chan, SC; Chang, JT; Chin, SC; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
Fan, W; Hu, YY; Liang, PY; Lin, XP; Zhang, WG; Zhang, X | 1 |
Abe, T; Fujita, H; Hayabuchi, N; Ishibashi, M; Kaibara, H; Kaida, H; Kobayashi, M; Kurata, S; Nakashima, T; Tanaka, N; Uchida, M; Uchiyama, Y | 1 |
Bol, A; Castadot, P; Geets, X; Grégoire, V; Lee, JA | 1 |
Chan, SC; Chang, JT; Liao, CT; Lin, CY; Lo, CW; Ng, SH; Wang, HM; Yen, TC | 1 |
Dubois, F; Dumollard, JM; Martin, C; Prades, JM; Prevot, N; Richard, C; Timoshenko, AP | 1 |
Aznar, M; Bender, E; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, S; Kristensen, CA; Specht, L; Tomé, W; Vogelius, I | 1 |
Chan, SC; Chin, SC; Liao, CT; Lin, CY; Ng, SH; Wai, YY; Wang, HM; Wang, JJ; Yen, TC | 1 |
Kawano, T; Kishimoto, S; Makino, T; Nakaminato, S; Shibuya, H; Toriihara, A | 1 |
Codreanu, I; Dasanu, CA; Divgi, C; Weinstein, GS | 1 |
Cannon, B; Dong, L; Schwartz, DL | 1 |
Choi, SH; Kim, JS; Kim, SY; Nam, SY; Park, GC; Roh, JL | 1 |
Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
Fujimoto, Y; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Maruo, T; Naganawa, S; Nakashima, T; Suzuki, H | 1 |
Dietz, A; Dollner, R; Harms, W; Henze, M; Jungehülsing, M; Rudat, V | 1 |
Fei, G; Perie, S | 1 |
Boér, A; Emri, M; Esik, O; Herzog, H; Lengyel, E; Lengyel, Z; Liszkay, G; Repa, I; Sáfrány, G; Szakáll, S; Trón, L | 1 |
Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K | 1 |
Conessa, C; Foehrenbach, H; Hervé, S; Poncet, JL | 1 |
Allen, AM; Haddad, RI; Tishler, RB | 1 |
Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, S; Nam, SY; Pae, KH; Roh, JL | 1 |
Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Hortling, N; Joe, AY; Palmedo, H | 1 |
Baumann, M; Bergmann, R; Beuthien-Baumann, B; Hessel, F; Kotzerke, J; Schütze, C; Steinbach, J; Yaromina, A | 1 |
Dietl, B; Kölbl, O; Marienhagen, J; Murthum, T | 1 |
Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
Arnold, W; Avril, N; Herz, M; Kau, RJ; Kruschke, C; Laubenbacher, C; Saumweber, D; Schwaiger, M; Wagner-Manslau, C; Ziegler, S | 1 |
Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
Dietz, A; Eisenhut, M; Haberkorn, U; Henze, M; Mier, W; Mohammed, A; Nollert, J; Rudat, V | 1 |
Haberkorn, U; Schadel, A; Seifert, E; Strauss, LG | 1 |
6 trial(s) available for fluorodeoxyglucose f18 and Hypopharyngeal Neoplasms
Article | Year |
---|---|
Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tumor Burden | 2010 |
¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
Topics: Biological Transport; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
[Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Salvage Therapy; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluoroscopy; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Iohexol; Leiomyosarcoma; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Topics: alpha-Methyltyrosine; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Iodine Radioisotopes; Laryngeal Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2002 |
50 other study(ies) available for fluorodeoxyglucose f18 and Hypopharyngeal Neoplasms
Article | Year |
---|---|
Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Risk Factors | 2023 |
Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma.
Topics: Adult; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate | 2019 |
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Topics: Aged; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2020 |
Follow up imaging of oral, oropharyngeal and hypopharyngeal cancer patients: Comparison of PET-CT and MRI post treatment.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study.
Topics: Aged; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Survival Analysis; Treatment Outcome; Tumor Burden | 2017 |
Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Tumor Burden | 2019 |
Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Hypopharyngeal Neoplasms; Male; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2019 |
Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Spine | 2019 |
Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv
Topics: Aged; Biomarkers; Combined Modality Therapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve | 2019 |
Extracapsular spread in hypopharyngeal squamous cell carcinoma: diagnostic value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Oropharyngeal Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2013 |
Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Tomography, X-Ray Computed | 2013 |
Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Clinical usefulness of [18F]FDG PET-CT and CT/MRI for detecting nodal metastasis in patients with hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2015 |
Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Papillomavirus Infections; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2014 |
Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Conformal; Response Evaluation Criteria in Solid Tumors; Survival Rate; Tomography, X-Ray Computed | 2015 |
Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2014 |
18F-FDG PET-CT as a supplement to CT/MRI for detection of nodal metastasis in hypopharyngeal SCC with palpably negative neck.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
Topics: Adult; Aged; Blood Glucose; Chemoradiotherapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Topics: Animals; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Mice, Nude; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy Dosage; Xenograft Model Antitumor Assays | 2016 |
Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Hypopharynx; Imaging, Three-Dimensional; Laryngeal Neoplasms; Laryngectomy; Larynx; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
[18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2017 |
[18F-FDG PET/CT for the detection of primary tumors metastasizing to lymph nodes of the neck].
Topics: Adolescent; Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Nasopharyngeal Neoplasms; Neck; Positron-Emission Tomography; Pyriform Sinus; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
[Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers].
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2009 |
18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Oropharyngeal Neoplasms; Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Fluorodeoxyglucose-induced allergic reaction: a case report.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Diphenhydramine; Drug Hypersensitivity; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Pyriform Sinus; Radiopharmaceuticals; Secondary Prevention; Squamous Cell Carcinoma of Head and Neck; Terfenadine; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Metabolic imaging biomarkers of postradiotherapy xerostomia.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Oropharyngeal Neoplasms; Parotid Gland; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Xerostomia | 2012 |
Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2013 |
[The role of 18F-FDG in hypopharyngeal cancer].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Radionuclide Imaging | 2003 |
PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation.
Topics: Butanols; Cell Survival; Dose-Response Relationship, Radiation; Female; Fibroblasts; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Methionine; Middle Aged; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Spinal Cord; Tomography, Emission-Computed | 2004 |
FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Retropharyngeal nodes in hypopharynx cancer on positron emission tomography.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Male; Neoplasm Staging; Pharynx; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Treatment Outcome | 2007 |
Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Incidental Findings; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Xenograft Model Antitumor Assays | 2007 |
[FDG-PET-CT based imaging of retropharyngeal lymph nodes with its impact on radiotherapy].
Topics: Antineoplastic Agents; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Endoscopy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1992 |